Skip to main content
Avicanna Inc. logo

Avicanna Inc. — Investor Relations & Filings

Ticker · AVCN ISIN · CA05368K1003 LEI · 254900AUQ4URGWO3FN90 TSX Manufacturing
Open in API
Filings indexed 484 across all filing types
Latest filing 2021-04-20 Capital/Financing Update
Country CA Canada
Listing TSX AVCN

About Avicanna Inc.

https://www.avicanna.com/

Avicanna is a commercial-stage international biopharmaceutical company focused on the advancement and commercialization of evidence-based, cannabinoid-based products for the global medical and pharmaceutical markets. The company operates through four commercial pillars: Medical Cannabis Products (RHO Phyto™), a Medical Cannabis Care Platform (MyMedi.ca), a Pharmaceutical Pipeline, and Active Pharmaceutical Ingredients (Aureus Santa Marta™). Avicanna leverages an industry-leading scientific platform, including R&D collaborations with academic institutions and a robust IP portfolio, resulting in over 50 proprietary commercialized SKUs.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Capital/Financing Update Classification · 90% confidence The document is a press release announcing the initial listings and sales of Avicanna's RHO Phyto products in Canadian adult use retail channels. It focuses on commercial expansion, product attributes, market strategy, and sales performance. There is no detailed financial data, regulatory filing, or report attached or referenced. The content is promotional and informative about business developments rather than a formal financial report or regulatory filing. It does not fit categories like Annual Report, Earnings Release, or Regulatory Filings. The document is best classified as a Capital/Financing Update (CAP) because it provides an update on the company's commercial activities and market expansion, which relates to business growth and potential revenue drivers.
2021-04-20 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the receipt of a Management Cease Trade Order (MCTO) due to the company's anticipated delay in filing its audited annual financial statements and related documents for the year ended December 31, 2020. It references the delay in filing the annual report documents but does not contain the actual financial statements or detailed financial data. The document provides a status update on the filing delay and regulatory compliance but does not present the annual report itself. The length is under 10,000 characters and the content is primarily an announcement regarding regulatory status and filing delays, not the report. Therefore, this is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance updates that do not fit other categories.
2021-04-12 English
Material change report - English.pdf
Regulatory Filings
2021-03-30 English
News release - English.pdf
Regulatory Filings
2021-03-30 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing that Avicanna's Colombian subsidiary has attained its 2021 THC production quota and completed its first commercial export of THC active pharmaceutical ingredients to Chile. It discusses operational milestones, export activities, and business developments related to cultivation quotas and product commercialization. There are no financial statements, detailed financial performance data, or regulatory filings such as annual or quarterly reports. The content is primarily an update on capital and operational activities related to production and export. Therefore, the document fits best under the category of Capital/Financing Update (CAP), as it relates to production quotas and commercial export activities which impact the company's capital and operational status.
2021-03-29 English
News release - English.pdf
Investor Presentation Classification · 95% confidence The document is a press release announcing the participation of Avicanna's CEO in two investor conferences on March 25, 2021. It provides background information about the company and its products but does not contain any financial data, regulatory filings, or detailed financial reports. There is no indication of an earnings release, annual or interim report, or any other formal filing. The content is primarily an investor presentation announcement or event participation notice. Given the nature of the document as an announcement of presentations at investor conferences, the most appropriate classification is Investor Presentation (IP). The document length is 4821 characters, which is consistent with a detailed announcement but not a full report.
2021-03-25 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.